307 related articles for article (PubMed ID: 26988995)
21. Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma.
Li L; Liu M; Lin JB; Hong XB; Chen WX; Guo H; Xu LY; Xu YW; Li EM; Peng YH
Dis Markers; 2017; 2017():2534648. PubMed ID: 28298808
[TBL] [Abstract][Full Text] [Related]
22. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
23. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.
Liao Y; Xing S; Xu B; Liu W; Zhang G
Oncotarget; 2017 May; 8(18):30050-30062. PubMed ID: 28415791
[TBL] [Abstract][Full Text] [Related]
25. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
Wang M; Liu F; Pan Y; Xu R; Li F; Liu A; Yang H; Duan L; Shen L; Wu Q; Liu Y; Liu M; Liu Z; Hu Z; Chen H; Cai H; He Z; Ke Y
EBioMedicine; 2021 Nov; 73():103674. PubMed ID: 34753106
[TBL] [Abstract][Full Text] [Related]
27. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of serum DKK-1 in patients with gynecological cancer.
Jiang T; Wang S; Huang L; Zhang S
Int J Gynecol Cancer; 2009 Oct; 19(7):1177-81. PubMed ID: 19820386
[TBL] [Abstract][Full Text] [Related]
29. Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
Kim SU; Park JH; Kim HS; Lee JM; Lee HG; Kim H; Choi SH; Baek S; Kim BK; Park JY; Kim DY; Ahn SH; Lee JD; Han KH
Yonsei Med J; 2015 Sep; 56(5):1296-306. PubMed ID: 26256972
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Cheng L; Ren P; Shi J; Dai L; Wang P; Zhang J
Oncoimmunology; 2020 Sep; 9(1):1814515. PubMed ID: 33457096
[TBL] [Abstract][Full Text] [Related]
31. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
[TBL] [Abstract][Full Text] [Related]
33. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
[TBL] [Abstract][Full Text] [Related]
34. Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma.
Zhang B; Zhang Z; Zhang X; Gao X; Kernstine KH; Zhong L
Biomarkers; 2012 Jun; 17(4):372-8. PubMed ID: 22515502
[TBL] [Abstract][Full Text] [Related]
35. Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma.
Cheng Y; Xu J; Guo J; Jin Y; Wang X; Zhang Q; Liu L
Clin Transl Oncol; 2013 May; 15(5):398-402. PubMed ID: 23054755
[TBL] [Abstract][Full Text] [Related]
36. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
[TBL] [Abstract][Full Text] [Related]
37. Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
Dong S; Yin H; Dong C; Sun K; Lv P; Meng W; Ming L; He F
Dis Markers; 2016; 2016():1857067. PubMed ID: 26989293
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma.
Sun G; Chen H; Xia J; Li T; Ye H; Li J; Zhang X; Cheng Y; Wang K; Shi J; Wang P
Int Immunopharmacol; 2023 Dec; 125(Pt A):111041. PubMed ID: 37866309
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
[TBL] [Abstract][Full Text] [Related]
40. Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma.
Ye L; Guan S; Zhang C; Lee KH; Sun S; Wei J; Liu B
Tumour Biol; 2013 Jun; 34(3):1873-7. PubMed ID: 23483489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
